Krzysztof Bankiewicz

This early-stage study is testing whether a gene therapy delivered directly to the brain is safe and might help people with young-onset Parkinson's disease. The therapy uses a modified virus to deliver a gene that helps brain cells produce more dopamine, the chemical that's low i…